Abrocitinib trials for Atopic Dermatitis

All Abrocitinib trials · All Atopic Dermatitis trials

Phase breakdown

Recruiting trials studying Abrocitinib for Atopic Dermatitis

• A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
  NCT06807281 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · 41 locations
• A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
  NCT05721937 · Phase: Not specified · Ages: 0 Years and older · Sex: Female · 1 location
• A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
  NCT05689151 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• Molecular Signatures in Inflammatory Skin Disease
  NCT03358693 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
  NCT06899204 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · 1 location
• Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
  NCT07242638 · Phase: Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Abrocitinib for Atopic Dermatitis?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.